Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 6Neoplasms 5Breast Neoplasms 3Testicular Neoplasms 2Polycystic Ovary Syndrome 2Sleep Apnea, Obstructive 1Sleep Apnea Syndromes 1Sexuality 1Sexual Dysfunction, Physiological 1Obesity 1Neoplasm Metastasis 1Muscle Weakness 1Multiple Endocrine Neoplasia Type 1 1Motor Activity 1Metabolic Syndrome 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Infertility 1Hypogonadism 1Hot Flashes 1Fatigue 1Dyspareunia 1Arthralgia 1

Interventions

Etoposide 22Carboplatin 22Filgrastim 17Ifosfamide 15Cisplatin 14Peripheral Blood Stem Cell Transplantation 12Paclitaxel 12Cyclophosphamide 9Bleomycin 9Thiotepa 5Radiotherapy 5Therapeutics 4Temozolomide 4Psychiatric Rehabilitation 4Oxaliplatin 4Melphalan 4Granulocyte Colony-Stimulating Factor 4Gemcitabine 4sargramostim 3pegfilgrastim 3etoposide phosphate 3Methylprednisolone 3Dexamethasone 3Busulfan 3liposomal amphotericin B 2ixabepilone 2aldesleukin 2aflibercept 2Trastuzumab 2Topotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Testicular Neoplasms × Testosterone × Clear all
NCT03339635 2024-07-30

Short-term Testosterone Replacement in Testicular Cancer Survivors

University Medical Center Groningen

Phase 2 Completed
32 enrolled
Genitourinary

Testicular Neoplasms

NCT02991209 2020-03-06

Einstein

Rigshospitalet, Denmark

Phase 2/3 Completed
69 enrolled
Genitourinary

Testicular Neoplasms, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡